Press Room

2018 ECA Conference: Spray Drying

Start
Tuesday, April 10, 2018 - 00:00
End
Thursday, April 12, 2018 - 00:00
Location: Lisbon, Portugal
Spray Drying Contract Manufacturing large capacity | Hovione

HOVIONE PRESENTATIONS

10th of April
Marriott Hotel, Lisbon - Portugal

Applications of Spray Drying for Inhalation Products: case-studies
Eunice Costa

Scale-Up of a Spray Drying Process
João Vicente

ASDs by Spray Drying Supporting the development of oral dosage forms Supporting the development of oral dosage forms
João Henriques

 

In this three days conference dedicated to Spray Drying solutions, on the last day attendees have the opportunity to take advantage of an exclusive hands-on training. For that purpose several spray dryers are available at Hovione.

Hovione hosts a hands-on spray drying session in its site in Loures (Workshop is fully booked).

Our experts provide an intensive experience and directly applicable know-how.

For more details about our tecnhologies contact us.

 

More Details on ECA website: Spray Drying With Guided Tour at the Hovione Site

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025